CITI Training Practice Exam

Question: 1 / 400

What should investigators reference when unsure if an IND is required for a study?

IND exemptions for studies of lawfully marketed drug or biological products for the treatment of cancer OR seek opinion from FDA

When determining if an IND is required for a study, the investigator should reference IND exemptions for studies of lawfully marketed drug or biological products for the treatment of cancer. This means that if the drug or biological product being used in the study is already approved by the FDA for treating cancer, an IND may not be necessary. B, C, and D are incorrect as they do not provide specific information about IND exemptions and may not be reliable sources in determining if an IND is required. Additionally, seeking opinion from the FDA is the best course of action as they are the regulating authority for IND and can provide the most accurate information.

Get further explanation with Examzify DeepDiveBeta

Consult a clinical trial handbook

Consult the healthcare institution's policy

Contact a pharmaceutical consultant

Next Question

Report this question

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy